The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Catatonia: Our current understanding of its diagnosis, treatment and pathophysiology
Open accessAbstract
Catatonia is a psychomotor syndrome that has been reported to occur in more than 10% of patients with acute psychiatric illnesses. Two subtypes of the syndrome have been identified. Catatonia of the retarded type is characterized by immobility, mutism, staring, rigidity, and a host of other clinical signs. Excited catatonia is a less common presentation in which patients develop prolonged periods of psychomotor agitation. Once thought to be a subtype of schizophrenia, catatonia is now recognized to occur with a broad spectrum of medical and psychiatric illnesses, particularly affective disorders. In many cases, the catatonia must be treated before any underlying conditions can be accurately diagnosed. Most patients with the syndrome respond rapidly to low-dose benzodiazepines, but electroconvulsive therapy is occasionally required. Patients with longstanding catatonia or a diagnosis of schizophrenia may be less likely to respond. The pathobiology of catatonia is poorly understood, although abnormalities in gamma-aminobutyric acid and glutamate signaling have been suggested as causative factors. Because catatonia is common, highly treatable, and associated with significant morbidity and mortality if left untreated, physicians should maintain a high level of suspicion for this complex clinical syndrome. Since 1989, we have systematically assessed patients presenting to our psychiatry service with signs of retarded catatonia. In this paper, we present a review of the current literature on catatonia along with findings from the 220 cases we have assessed and treated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detecting awareness in the vegetative state
Owen, A. M., Coleman, M. R., Boly, M., Davis, M. H., Laureys, S., & Pickard, J. D. (2006) · Science · doi:10.1126/science.1130197 · Cited by 1,978
Catatonia. I. Rating scale and standardized examination
Bush, G., Fink, M., Petrides, G., Dowling, F., & Francis, A. (1996) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1996.tb09814.x · Cited by 1,101
Bedside detection of awareness in the vegetative state: a cohort study
Cruse, D., Chennu, S., Chatelle, C., Bekinschtein, T. A., Fernández-Espejo, D., Pickard, J. D., Laureys, S., & Owen, A. M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61224-5 · Cited by 712
Catatonia in Psychiatric Classification: A Home of Its Own
Taylor, M. A., & Fink, M. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1233 · Cited by 581
Neuroleptic Malignant Syndrome
Strawn, J. R., Keck, P. E., & Caroff, S. N. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.6.870 · Cited by 579
Neuroleptic malignant syndrome
Caroff, S. N., & Mann, S. C. (1993) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30278-4 · Cited by 514
Varieties of the locked-in syndrome
Bauer, G., Gerstenbrand, F., & Rumpl, E. (1979) · Journal of Neurology · doi:10.1007/bf00313105 · Cited by 504
(1990) · PubMed · Cited by 343
A Clinical Review of the Treatment of Catatonia
Sienaert, P., Dhossche, D. M., Vancampfort, D., De Hert, M., & Gazdag, G. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00181 · Cited by 339
Catatonia: A Prospective Clinical Study
Abrams, R. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770050043006 · Cited by 325
Stiff-Man Syndrome and Variants: Clinical Course, Treatments, and Outcomes
McKeon, A. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.991 · Cited by 300
A prospective analysis of 24 episodes of neuroleptic malignant syndrome
(1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.6.717 · Cited by 292
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.11.1374 · Cited by 288
Neuroleptic Malignant Syndrome and Atypical Antipsychotic Drugs
Ananth, J., Parameswaran, S., Gunatilake, S., Burgoyne, K., & Sidhom, T. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0403 · Cited by 273
Extrapyramidal side-effects of antipsychotics in a randomised trial
Miller, D. D., Caroff, S. N., Davis, S. M., Rosenheck, R. A., McEvoy, J. P., Saltz, B. L., Riggio, S., Chakos, M. H., Swartz, M. S., Keefe, R. S. E., et al. (2008) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.050088 · Cited by 265
Tandon, R., Heckers, S., Bustillo, J., Barch, D. M., Gaebel, W., Gur, R. E., Malaspina, D., Owen, M. J., Schultz, S., Tsuang, M., et al. (2013) · Schizophrenia Research · doi:10.1016/j.schres.2013.04.034 · Cited by 250
Rosebush, P. I., & Mazurek, M. F. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp141 · Cited by 249
Self-citationDisorders of diminished motivation
Marin, R. S., & Wilkosz, P. A. (2005) · Journal of Head Trauma Rehabilitation · doi:10.1097/00001199-200507000-00009 · Cited by 241
Fink, M., Shorter, E., & Taylor, M. A. (2010) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp059 · Cited by 223
Catatonic Reactions to High-Potency Neuroleptic Drugs
Gelenberg, A. J. (1977) · Archives of General Psychiatry · doi:10.1001/archpsyc.1977.01770200085010 · Cited by 215
"Scared Stiff": Catatonia as an Evolutionary-Based Fear Response.
Moskowitz, A. K. (2004) · Psychological Review · doi:10.1037/0033-295x.111.4.984 · Cited by 207
Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.12.1587 · Cited by 183
Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled cross-over study
Ungvari, G. S., Chiu, H. F. K., Chow, L. Y., Lau, B. S. T., & Tang, W. K. (1999) · Psychopharmacology · doi:10.1007/s002130050904 · Cited by 182
Somatic Treatment of Catatonia
Hawkins, J. M., Archer, K. J., Strakowski, S. M., & Keck, P. E. (1995) · The International Journal of Psychiatry in Medicine · doi:10.2190/x0ff-vu7g-qqp7-l5v7 · Cited by 177
Benzodiazepines in the treatment of catatonic syndrome
Ungvari, G. S., Leung, C. M., Wong, M. K., & Lau, J. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01515.x · Cited by 166
Neuroleptic malignant syndrome and catatonia: One entity or two?
Fink, M. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00552-8 · Cited by 164
Review of Adjunctive Glutamate Antagonist Therapy in the Treatment of Catatonic Syndromes
Carroll, B. T., Goforth, H. W., Thomas, C., Ahuja, N., McDaniel, W. W., Kraus, M. F., Spiegel, D. R., Franco, K. N., Pozuelo, L., & Munoz, C. (2007) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.19.4.406 · Cited by 163
Catatonia: Retarded and Excited Types
Morrison, J. R. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750310023005 · Cited by 162
Presentation, Evaluation, and Treatment of Nonconvulsive Status Epilepticus
Drislane, F. W. (2000) · Epilepsy & Behavior · doi:10.1006/ebeh.2000.0100 · Cited by 162
Catatonia and neuroleptic malignant syndrome: psychopathology and pathophysiology
Northoff, G. (2002) · Journal of Neural Transmission · doi:10.1007/s00702-002-0762-z · Cited by 162
Nonconvulsive status epilepticus
Maganti, R. K., Gerber, P., Drees, C., & Chung, S. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2007.12.002 · Cited by 145
Serum iron and neuroleptic malignant syndrome
Rosebush, P. I., Mazurek, M. F., & Mazurek, M. F. (1991) · The Lancet · doi:10.1016/0140-6736(91)90138-f · Cited by 131
Self-citationSerum iron in catatonia and neuroleptic malignant syndrome
Lee, J. W. Y. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00109-7 · Cited by 124
[Neuroleptic malignant syndrome].
Gázquez, J. M. C. D. L. B., Montero‐Pérez, F. J., Sánchez Medina, C., & Murillo, L. M. J. (1992) · PubMed · Cited by 124
Catatonia in a Psychiatric Intensive Care Facility: Incidence and Response to Benzodiazepines
Lee, J. W. Y., Schwartz, D., & Hallmayer, J. F. (2000) · Annals of Clinical Psychiatry · doi:10.1023/a:1009072130267 · Cited by 122
Clinebell, K., Azzam, P. N., Gopalan, P. R., & Haskett, R. F. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08870 · Cited by 119
Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidone
Rosebush, P. I., & Mazurek, M. F. (1999) · Neurology · doi:10.1212/wnl.52.4.782 · Cited by 119
Self-citationNonconvulsive Status Epilepticus
Nagayama, M., & Yang, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-7272-8_12 · Cited by 117
Motor features in psychotic disorders. II
Peralta, V., & Cuesta, M. J. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00035-9 · Cited by 102
Peralta, V., Campos, M., de Jalón, E. G., & Cuesta, M. J. (2010) · Schizophrenia Research · doi:10.1016/j.schres.2009.12.023 · Cited by 98
Catatonic Disorder Due to a General Medical or Psychiatric Condition
Smith, J. H., Smith, V. D., Philbrick, K. L., & Kumar, N. (2012) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.11060120 · Cited by 98
Catatonia in autism: implications across the life span
Kakooza‐Mwesige, A., Wachtel, L. E., & Dhossche, D. M. (2008) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-008-0676-x · Cited by 93
Catatonia After Benzodiazepine Withdrawal
Rosebush, P. I., & Mazurek, M. F. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199608000-00007 · Cited by 89
Self-citationDhossche, D. M., Stoppelbein, L., & Rout, U. K. (2010) · Journal of Ect · doi:10.1097/yct.0b013e3181fbf96d · Cited by 86
Weder, N. D., Muralee, S., Penland, H. R., & Tampi, R. R. (2008) · Annals of Clinical Psychiatry · doi:10.1080/10401230802017092 · Cited by 81
Neuroleptic Malignant Syndrome
Caroff, S. N., Mann, S. C., & Lazarus, A. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800210090015 · Cited by 79
Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers.
Gaind, G. S., Rosebush, P. I., & Mazurek, M. F. (1994) · PubMed · Cited by 78
Self-citationCatatonia in Psychotic Patients: Clinical Features and Treatment Response
England, M. L., Öngür, D., Konopaske, G. T., & Karmacharya, R. (2011) · Journal of Neuropsychiatry · doi:10.1176/jnp.23.2.jnp223 · Cited by 76
Medda, P., Toni, C., Luchini, F., Mariani, M. G., Mauri, M., & Perugi, G. (2015) · Bipolar Disorders · doi:10.1111/bdi.12348 · Cited by 67
Epidemiology of neuroleptic malignant syndrome.
Adityanjee, Aderibigbe, Y. A., & Mathews, T. (1999) · PubMed · Cited by 66
Electroconvulsive therapy in Lorazepam non-responsive catatonia.
Girish, K., & Gill, N. (2003) · PubMed Central · Cited by 65
Catatonia, Lethal Catatonia, and Neuroleptic Malignant Syndrome
Fricchione, G. L., Mann, S. C., & Caroff, S. N. (2000) · Psychiatric Annals · doi:10.3928/0048-5713-20000501-12 · Cited by 65
Maximal Response to Electroconvulsive Therapy for the Treatment of Catatonic Symptoms
Hatta, K., Miyakawa, K., Ota, T., Usui, C., Nakamura, H., & Arai, H. (2007) · Journal of Ect · doi:10.1097/yct.0b013e3181587949 · Cited by 59
Catatonia: Re-awakening to a forgotten disorder
Rosebush, P. I., & Mazurek, M. F. (1999) · Movement Disorders · doi:10.1002/1531-8257(199905)14:3<395::aid-mds1002>3.0.co;2-l · Cited by 56
Self-citationEEG Findings in the Persistent Vegetative State
Kulkarni, V. P., Lin, K.-W., & Benbadis, S. R. (2007) · Journal of Clinical Neurophysiology · doi:10.1097/wnp.0b013e31815c2810 · Cited by 44
An Analysis of 17 Catatonic Patients Diagnosed With Neuroleptic Malignant Syndrome
White, D. A. C., & Robins, A. H. (2000) · CNS Spectrums · doi:10.1017/s1092852900013419 · Cited by 43
Treatment of Catatonia With Zolpidem
Peglow, S. L., Prem, V., & McDaniel, W. W. (2013) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.11120367 · Cited by 37
Clonazepam Withdrawal-Induced Catatonia
Brown, M., & Freeman, S. A. (2009) · Psychosomatics · doi:10.1176/appi.psy.50.3.289 · Cited by 34
Symptom profile and short term outcome of catatonia: an exploratory clinical study
Dubale, B. W., & Fekadu, A. (2015) · BMC Psychiatry · doi:10.1186/s12888-015-0554-2 · Cited by 28
Long-term maintenance lorazepam for catatonia: a case report
Grover, S., & Aggarwal, M. (2010) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2010.06.006 · Cited by 27
Ellul, P., Rotgé, J., & Choucha, W. (2015) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2015.0064 · Cited by 24
Catatonia in French Psychiatry: Implications of the Zolpidem Challenge Test
(2007) · Psychiatric Annals · doi:10.3928/00485713-20070101-02 · Cited by 19
Treatment refractory chronic catatonia responsive to zolpidem challenge
Bastiampillai, T. J., McGovern, V., Lloyd, B., Lingappa, S. H., & Nelson, A. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415582232 · Cited by 15
Cited by
Peralta, V., & Cuesta, M. J. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx089 · Cited by 133
Lorazepam in catatonia – Past, present and future of a clinical success story
Hirjak, D., Fricchione, G., Wolf, R. C., & Northoff, G. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2023.02.015 · Cited by 36
Giblin, K. A., Basili, D., Afzal, A. M., Rosenbrier-Ribeiro, L., Greene, N., Barrett, I., Hughes, S. J., & Bender, A. (2021) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00311 · Cited by 18
Metadata
- Authors
- Rasmussen, S. A., Mazurek, M. F., & Rosebush, P. I.
- Venue
- World Journal of Psychiatry
- Publisher
- Baishideng Publishing Group Inc.
- Published
- 2016
- Volume
- 6
- Issue
- 4
- Pages
- 391
- ISSN
- 2220-3206 (ISSN-L)
- OpenAlex
- W2564535246
- Cited by
- 334
- References
- 63
- FWCI
- 13.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.